These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 29594582)

  • 81. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Encapsulating pH-Responsive Doxorubicin-Phthalocyanine Conjugates in Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Controlled Chemotherapy.
    Wong RCH; Ng DKP; Fong WP; Lo PC
    Chemistry; 2017 Nov; 23(65):16505-16515. PubMed ID: 28771861
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Graphene quantum dot based charge-reversal nanomaterial for nucleus-targeted drug delivery and efficiency controllable photodynamic therapy.
    Ju J; Regmi S; Fu A; Lim S; Liu Q
    J Biophotonics; 2019 Jun; 12(6):e201800367. PubMed ID: 30701677
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery.
    Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z
    Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hyaluronic acid targeted and pH-responsive nanocarriers based on hollow mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
    Chen K; Chang C; Liu Z; Zhou Y; Xu Q; Li C; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111166. PubMed ID: 32521461
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs.
    Kwon S; Singh RK; Kim TH; Patel KD; Kim JJ; Chrzanowski W; Kim HW
    Acta Biomater; 2014 Mar; 10(3):1431-42. PubMed ID: 24239681
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery.
    Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF
    Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
    An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.
    Shen J; He Q; Gao Y; Shi J; Li Y
    Nanoscale; 2011 Oct; 3(10):4314-22. PubMed ID: 21892492
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
    Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X
    Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery.
    Zhang J; Wu D; Li MF; Feng J
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26666-73. PubMed ID: 26553405
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Enriching Mn-Doped ZnSe Quantum Dots onto Mesoporous Silica Nanoparticles for Enhanced Fluorescence/Magnetic Resonance Imaging Dual-Modal Bio-Imaging.
    Zhou R; Sun S; Li C; Wu L; Hou X; Wu P
    ACS Appl Mater Interfaces; 2018 Oct; 10(40):34060-34067. PubMed ID: 30211537
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging.
    He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C
    Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295
    [TBL] [Abstract][Full Text] [Related]  

  • 94. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
    Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
    Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Targeting N-doped graphene quantum dot with high photothermal conversion efficiency for dual-mode imaging and therapy in vitro.
    Xuan Y; Zhang RY; Zhang XS; An J; Cheng K; Li C; Hou XL; Zhao YD
    Nanotechnology; 2018 Aug; 29(35):355101. PubMed ID: 29873637
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
    Li J; Du X; Zheng N; Xu L; Xu J; Li S
    Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Label-free luminescent mesoporous silica nanoparticles for imaging and drug delivery.
    Chen H; Zhen Z; Tang W; Todd T; Chuang YJ; Wang L; Pan Z; Xie J
    Theranostics; 2013; 3(9):650-7. PubMed ID: 24052805
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Fluorescent graphene oxide via polymer grafting: an efficient nanocarrier for both hydrophilic and hydrophobic drugs.
    Kundu A; Nandi S; Das P; Nandi AK
    ACS Appl Mater Interfaces; 2015 Feb; 7(6):3512-23. PubMed ID: 25612470
    [TBL] [Abstract][Full Text] [Related]  

  • 99. One-pot green synthesis of doxorubicin loaded-silica nanoparticles for in vivo cancer therapy.
    Jiang S; Hua L; Guo Z; Sun L
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():257-263. PubMed ID: 29853089
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Reduction/pH dual-sensitive PEGylated hyaluronan nanoparticles for targeted doxorubicin delivery.
    Xu M; Qian J; Suo A; Wang H; Yong X; Liu X; Liu R
    Carbohydr Polym; 2013 Oct; 98(1):181-8. PubMed ID: 23987334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.